Minnesota-founded microbial analysis spinout CoreBiome has been bought by medical diagnostics firm OraSure Technology after raising $1.4m from investors including Minnesota’s Discovery Capital fund.

CoreBiome, a microbial analysis technology spinout of University of Minnesota, was acquired by medical diagnostics kit manufacturer OraSure Technologies for an undisclosed sum on Thursday.
The transaction is expected to be finalised within the coming days.
Founded in 2016, CoreBiome develops research sampling and analysis products for microbiomes, the sum of genetic material which forms microorganism communities in environments such as the human gut.
The products utilise machine learning technology to build genomic profiles of the microbiomes for purposes including human health, agriculture and environmental monitoring.
Following the acquisition, CoreBiome’s underlying technology will be integrated to augment the product line of OraSure’s biological sampling subsidiary, DNA Genotek.
CoreBiome was formed on the back of research conducted by Dan Knights, an associate professor of computer science and engineering in the College of Science and Engineering as well as in the Biotechnology Institute at the College of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?